Table 4.

Correlation between genomic copy number change and clinical feature




P

OS association
TTF association
Chr and position, Mpb
Change
Greater
Lesser
Greater
Lesser
Other association (P)
1       
1.5-9.0   Loss   —   —   —   —   Older than 60 y at diagnosis (.038)  
78.2-79.1   Loss   .014*  —   .021   —   —  
2       
2.4-4.1   Loss   —   .024*  —   —   —  
104.2-159.9   Loss   —   —   —    Low stage (.006)  
3       
0.2-204.6   Gain   .048   —   .036   —   Low PS (.015), low IPI (.007)  
137.4-188.7   Gain   —   —   —   —   Low PS (.029), low IPI (.014)  
4       
24.9-34.7   Loss   .046   —   .011   —   —  
5       
0-0.5   Gain   —   —   —   —   Low PS (.029)  
6       
62.2-170.5   Loss   —   —   .009   —   —  
7       
11.7-17.3   Loss   —   —   —   —   END present (.049)  
18.8-19.3   Loss   —   —   —   —   END present (.030)  
8       
14.9-22.6   Loss   —   —   —   —   High PS (.036)  
9       
8.3-12.5   Loss   —   —   .026   —   —  
117.6-134.3   Gain   .025   —   —   —   —  
122.1-132.8   Gain   .014   —   —   —   —  
10       
102.1-102.9   Gain   —   —   —   —   Low PS (.035)  
107.0-120.0   Loss   —   —   .039   —   —  
13       
85-91.9   Gain   —   .026   —   .027   —  
14       
86.7-105.1   Loss   —   —   —   —   High LDH (.043)  
90.1-105.1   Loss   —   —   —   —   High LDH (.043)  
15       
41.2-45.5   Loss   —   —   .042   —   —  
16       
33.8-35.6   Loss   —   <.001*  —   .002   —  
18       
66.2-66.6   Loss   —   —   —   —   High LDH (.043)  
19       
0.2-63.7   Gain   .047   —   .049   —   Low LDH (.034), low PS (.038)  
43.1-63.7   Gain   .032   —   .032   —   Low LDH (.015), low PS (.020)  
20       
22.5-63.6   Gain   .045   —   —   —   —  
21       
15.1-46.9   Gain   —   —   —   —   Low PS (.020)  
29.4-46.9
 
Gain
 

 

 

 

 
Low PS (.020)
 



P

OS association
TTF association
Chr and position, Mpb
Change
Greater
Lesser
Greater
Lesser
Other association (P)
1       
1.5-9.0   Loss   —   —   —   —   Older than 60 y at diagnosis (.038)  
78.2-79.1   Loss   .014*  —   .021   —   —  
2       
2.4-4.1   Loss   —   .024*  —   —   —  
104.2-159.9   Loss   —   —   —    Low stage (.006)  
3       
0.2-204.6   Gain   .048   —   .036   —   Low PS (.015), low IPI (.007)  
137.4-188.7   Gain   —   —   —   —   Low PS (.029), low IPI (.014)  
4       
24.9-34.7   Loss   .046   —   .011   —   —  
5       
0-0.5   Gain   —   —   —   —   Low PS (.029)  
6       
62.2-170.5   Loss   —   —   .009   —   —  
7       
11.7-17.3   Loss   —   —   —   —   END present (.049)  
18.8-19.3   Loss   —   —   —   —   END present (.030)  
8       
14.9-22.6   Loss   —   —   —   —   High PS (.036)  
9       
8.3-12.5   Loss   —   —   .026   —   —  
117.6-134.3   Gain   .025   —   —   —   —  
122.1-132.8   Gain   .014   —   —   —   —  
10       
102.1-102.9   Gain   —   —   —   —   Low PS (.035)  
107.0-120.0   Loss   —   —   .039   —   —  
13       
85-91.9   Gain   —   .026   —   .027   —  
14       
86.7-105.1   Loss   —   —   —   —   High LDH (.043)  
90.1-105.1   Loss   —   —   —   —   High LDH (.043)  
15       
41.2-45.5   Loss   —   —   .042   —   —  
16       
33.8-35.6   Loss   —   <.001*  —   .002   —  
18       
66.2-66.6   Loss   —   —   —   —   High LDH (.043)  
19       
0.2-63.7   Gain   .047   —   .049   —   Low LDH (.034), low PS (.038)  
43.1-63.7   Gain   .032   —   .032   —   Low LDH (.015), low PS (.020)  
20       
22.5-63.6   Gain   .045   —   —   —   —  
21       
15.1-46.9   Gain   —   —   —   —   Low PS (.020)  
29.4-46.9
 
Gain
 

 

 

 

 
Low PS (.020)
 

Chr indicates chromosome; —, not significant.

*

Values that remained significantly associated with OS (P < .05) after multivariate analysis with IPI.

Close Modal

or Create an Account

Close Modal
Close Modal